Abing, Sarah B.
HRN: 03-76-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2025
CEFTRIAXONE 1G (VIAL)
03/13/2025
03/20/2025
IV
2 Grams
Once Daily
CAP MR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes